A 60-year-old women with a 40-year history of refractory Hailey-Hailey disease and type 2 diabetes received liraglutide 1.8 mg SC for 6 months, after which she had near complete resolution of lesions on her neck, axillae, and inguinal and abdominal folds as well as resolution of associated pain
Yes, different facial areas and body regions often benefit from different concentrations
The new addition is glucagon agonism, which brings its own side effect profile but builds on a tolerated foundation
10.26355/eurrev_201808_15723 29 ChenJ.MangelinckxS.AdamsA.WangZ
why the benefit is largest in the stressed and nil in the calm
Nauck MA, Meier JJ (2016) The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions